The Biden administration said there was no cause for retaliation from Beijing after its communist leadership criticized Washington’s decision to require a negative COVID-19 test from those who travel from China to the United States.
“There’s no cause for retaliation here just because countries around the world are taking prudent health measures to protect their citizens,” White House press secretary Karine Jean-Pierre said during a Jan. 3 press conference.
“That’s what you’re seeing from us and others.”
The move prompted a global outcry, and nations around the world are hurrying to put in place testing requirements for all arrivals from China.
The United States joins the UK, Australia, Canada, France, India, Italy, Japan, South Korea, Spain, Malaysia, Qatar, and other nations seeking to place stronger restrictions on arrivals from China.
World Prepares for China’s COVID Surge
The White House defended the decision to require testing from all China-originating travelers based on the international consensus that COVID-19 is currently ravaging China’s populace.“Again, there is no need for retaliation,” Jean-Pierre said. “This is something that all of us, other countries, are doing to make sure that we are protecting our citizens.
“This decision is based on public health and science. This is coming from our experts here. And other countries like Japan, like South Korea, the UK, France, India, Italy, and Malaysia are also taking similar public steps.”
The CCP has attempted to cover up the scale of COVID-19 infections in China and the number of deaths it’s causing among the Chinese population, which has no natural immunity following almost three years of constant lockdowns.
Cumulative deaths in China since Dec. 1, 2022, have probably reached 161,000, the report said.
The White House appeared to agree with that assessment, and Jean-Pierre reiterated that the WHO was demanding that the CCP release factual information about the state of COVID-19 in China.
“The World Health Organization is calling on China to release more data, which is vital ... to identify any potential variants.”